Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shorvon

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
British Medical Journal|May 17, 1980
Compliance and epilepsyS Shorvon, A W Galbraith, E H Reynolds
CNS Drugs|August 29, 2001
Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisationE Perucca, O Dulac, S Shorvon, et al.
Journal of Anatomy|April 1, 1996
MRI-based surface area estimates in the normal adult human brain: evidence for structural organisationS Sisodiya, S Free, D Fish, et al.
Archives of Neurology|March 1, 1992
Comparison of the effects of frontal and temporal lobe partial seizures on prolactin levelsH Meierkord, S Shorvon, S Lightman, et al.
Neuroepidemiology|January 1, 1990
A quantitative approach to measuring the social effects of epilepsyJ E Chaplin, R Yepez, S Shorvon, et al.
Epilepsy & Behavior : E&B|May 9, 2015
Preliminary results of the global audit of treatment of refractory status epilepticusM Ferlisi, S Hocker, M Grade, et al.
Health Trends|October 7, 1987
The framework of medical care for epilepsyJ Oxley, M Espir, S Shorvon, et al.
Epilepsy Research|August 15, 2000
Assessing risk to benefit ratio in antiepileptic drug therapyE Perucca, E Beghi, O Dulac, et al.
Neurology|January 30, 2008
Limited chronic focal encephalitis: another variant of Rasmussen syndrome?A Gambardella, F Andermann, S Shorvon, et al.
Seizure|January 15, 1999
Epilepsy needs revisited: a revised epilepsy needs document for the UKS Brown, T Betts, P Crawford, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
British Medical Journal|May 17, 1980
Compliance and epilepsyS Shorvon, A W Galbraith, E H Reynolds
CNS Drugs|August 29, 2001
Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisationE Perucca, O Dulac, S Shorvon, et al.
Journal of Anatomy|April 1, 1996
MRI-based surface area estimates in the normal adult human brain: evidence for structural organisationS Sisodiya, S Free, D Fish, et al.
Archives of Neurology|March 1, 1992
Comparison of the effects of frontal and temporal lobe partial seizures on prolactin levelsH Meierkord, S Shorvon, S Lightman, et al.
Neuroepidemiology|January 1, 1990
A quantitative approach to measuring the social effects of epilepsyJ E Chaplin, R Yepez, S Shorvon, et al.
Epilepsy & Behavior : E&B|May 9, 2015
Preliminary results of the global audit of treatment of refractory status epilepticusM Ferlisi, S Hocker, M Grade, et al.
Health Trends|October 7, 1987
The framework of medical care for epilepsyJ Oxley, M Espir, S Shorvon, et al.
Epilepsy Research|August 15, 2000
Assessing risk to benefit ratio in antiepileptic drug therapyE Perucca, E Beghi, O Dulac, et al.
Neurology|January 30, 2008
Limited chronic focal encephalitis: another variant of Rasmussen syndrome?A Gambardella, F Andermann, S Shorvon, et al.
Seizure|January 15, 1999
Epilepsy needs revisited: a revised epilepsy needs document for the UKS Brown, T Betts, P Crawford, et al.
Pageof 5